Hubei halfsky pharmaceutical consists of Hainan halfsky pharmaceutical company, Wuhan halfsky pharmaceutical company, Wuhan halfsky technology company and Hubei halfsky pharmaceutical company. Is a national focus on anti-tumor, pediatric medicine, parenteral nutrition support preparations and API research and development, production and sales of biological medicineState-level high-tech enterprises.

The company's research and development center is located in Wuhan East Lake High-tech Optical Valley Biological City, the existing research and development personnel of 50 people, including 10 doctors, master 15 people. R & D center existing area of 7000 square meters. Invested 0.15 billion yuan successively for the purchase of research and development equipment and instruments.

The company introduced the Central Organization Department"National Thousand Plan"Chinese-American Professor Li Jianguang as Chief Scientist; and Academician Wang Guangji of China Pharmaceutical University established"Academician Workstation"; December 2018National Ministry of Science and Technology, Health Commission"Major New Drug Creation"Special 4 items, of which, innovative drug compound amino acid injection 18AA-V-SF, 14AA-SF varieties, belong to the national exclusive varieties, "Chinese Pharmacopoeia" standard drafting research unit, respectively.January 2020, March 2021Included in the national negotiated health insurance drug catalog; the company'sJanuary 2021Approved by the State Administration of Drug Administration"Key Laboratory of Preparation Quality Research and Control".

The company has won the province"Enterprise Technology Center", "Provincial Cancer Nutrition Drug Engineering Research Center", "Provincial Intellectual Property Demonstration Enterprise", "High-tech Enterprise" of Ministry of Science and Technology, Provincial "High-value Intellectual Property Cultivation Enterprise", "Intellectual Property Application Demonstration Enterprise"Certificate. 2016 "Gemcitabine Hydrochloride and Preparation Key Technology Research" by the provincial governmentSecond prize for scientific and technological progress". Obtain in 2018"National Employment and Social Security Advanced Private Enterprises"Provincial Science and Technology Department"Double Creation Strategy Team"Title. In 2019, it was rated by the Provincial Department of Industry and Information Technology."The province's pillar industry segmentation field invisible champion", the province's "intelligent manufacturing demonstration enterprise".

During the epidemic, the company actively donated drugs to some hospitals across the country and donated materials to charitable units and medical institutions in the province, with a cumulative amount of more than 1000 million yuan.